Filter
184
Filtered Results: 184
Text search:
delamanid
Featured
Recommendations
30
New Publications
40
Language
Document type
No document type
96
Guidelines
36
Studies & Reports
21
Manuals
14
Training Material
6
Strategic & Response Plan
4
Fact sheets
3
Situation Updates
2
Brochures
1
Infographics
1
Countries / Regions
Western and Central Europe
15
Eastern Europe
11
South Africa
6
Argentina
5
Global
4
Latin America and the Carribbean
4
Germany
4
Bolivia
3
India
3
Nigeria
2
Malawi
2
Asia
2
South–East Asia Region
2
Eastern Europe and Central Asia
2
Russia
2
Ethiopia
2
Tajikistan
1
Switzerland
1
Colombia
1
Ukraine
1
Turkey
1
Estonia
1
Burkina Faso
1
Peru
1
Guinea
1
Guinea-Bissau
1
Venezuela
1
Congo, Democratic Republic of
1
West and Central Africa
1
Paraguay
1
East and Southern Africa
1
Brazil
1
Namibia
1
Romania
1
Georgia
1
Central African Republic
1
Chad
1
Botswana
1
Zambia
1
Authors & Publishers
Publication Years
Category
Clinical Guidelines
42
Countries
40
Public Health
5
Key Resources
3
Pharmacy & Technologies
3
Women & Child Health
2
Toolboxes
TB
122
COVID-19
10
HIV
9
Caregiver
9
Pharmacy
6
Mental Health
3
Refugee
3
Global Health Education
3
AMR
3
Ebola & Marburg
2
NTDs
2
Conflict
2
Rapid Response
1
Disability
1
Social Ethics
1
Planetary Health
1
Health Financing Toolbox
1
Polio
1
2nd edition.
T The Compendium has been developed as a clear and concise instrument to facilitate the understanding and planning of delivery of high-quality care for everybody affected by TB. It incorporates all recent policy guidance from WHO; follows the care pathway of persons with signs or sympt...
A survival guide for clinicans.
3rd edition.
Policy framework.
NSP Review
Engaging with South Africa’s National Strategic Plan for HIV, STIs and TB Edition 7 July – August 2013
A publication of the Treatment Action Campaign and SECTION27
GeneXpert: An imperfect rollout
TB in South African prisons: Where to now?
Decentralising DR-TB care: How far alon...
This document aims to provide concrete, pragmatic guidance for how TB modelling and related technical assistance is undertaken to support country decision-making. The target audience for this document are the participants and stakeholders in country-level TB modelling efforts, including the individu...
NOVEMBER 2012
This document serves as an update to “Out of the Dark”, a report published by MSF in October 2011, highlighting the need to prioritise the long-neglected area of paediatric tuberculosis (TB). This update will outline the key improvements and setbacks—the ‘highlights’ and ‘...
Towards ending tuberculosis and multidrug-resistant tuberculosis.
A review of available evidence (2016).
28-29 June 2016; Geneva, Switzerland
The END TB strategy.
Tuberculosis (TB) is, and should be, a curable disease; however, each year significant numbers of patients acquire or develop drug-resistant TB, which has a much lower cure rate. Patients with drug-resistant TB have a high prevalence of symptoms; hence, staff caring for these patients should h...
Each year since 2007, G-FINDER has provided policy-makers, donors, researchers and industry with a comprehensive analysis of global investment into research and development of new products to
prevent, diagnose, control or cure neglected diseases in low- and middle-income countries, making it the go...
Ce guide sur la tuberculose résistante est un outil pratique destiné à aider les agents de santé à prendre en charge le malade du point de vue clinique et opérationnel en mettant l’accent sur la décision thérapeutique, la mise en œuvre et le suivi du régime court de 9 mois pour le traite...
The Global Strategy for Tuberculosis Research and Innovation will support the efforts of governments and other stakeholders to accelerate TB research and innovation, and improve equitable access to the benefits of research.
Availabl in Arabic, Chinese, English, French, Spanish and Russian
